Paredes-Moscosso S, Nathwani A
Front Oncol. 2025; 14:1429330.
PMID: 39759138
PMC: 11696039.
DOI: 10.3389/fonc.2024.1429330.
Haggstrom L, Chan W, Nagrial A, Chantrill L, Sim H, Yip D
Cochrane Database Syst Rev. 2024; 12:CD011044.
PMID: 39635901
PMC: 11619003.
DOI: 10.1002/14651858.CD011044.pub3.
Sakaue T, Koga H, Iwamoto H, Nakamura T, Masuda A, Tanaka T
Gastro Hep Adv. 2024; 3(6):761-772.
PMID: 39280916
PMC: 11401553.
DOI: 10.1016/j.gastha.2024.04.011.
Hanada K, Shimizu A, Tsushima K, Kobayashi M
Diagnostics (Basel). 2024; 14(17).
PMID: 39272705
PMC: 11394136.
DOI: 10.3390/diagnostics14171920.
Quatromoni J, Roses R, Lee M, Jackson O, Jackson B, Gaffey A
J Vasc Surg Cases Innov Tech. 2024; 10(4):101540.
PMID: 38989262
PMC: 11234095.
DOI: 10.1016/j.jvscit.2024.101540.
Comparative Assessment of Endoscopic Ultrasound-Guided Biopsies vs. Percutaneous Biopsies of Pancreatic Lesions: A Systematic Review and Meta-Analysis of Diagnostic Performance.
Paramythiotis D, Karlafti E, Tsavdaris D, Arvanitakis K, Protopapas A, Germanidis G
J Clin Med. 2024; 13(11).
PMID: 38892819
PMC: 11172871.
DOI: 10.3390/jcm13113108.
Endoscopic ultrasound-guided gastroenterostomy enteral stenting for gastric outlet obstruction: a systematic review and meta-analysis.
Asghar M, Forcione D, Puli S
Therap Adv Gastroenterol. 2024; 17:17562848241248219.
PMID: 38855340
PMC: 11159541.
DOI: 10.1177/17562848241248219.
Radiation-Activated Cobalamin-Kinase Inhibitors for Treatment of Pancreatic Ductal Adenocarcinoma.
Gendron L, Sheveland C, Gunn J, Pogue B, Shell T, Shell J
Mol Pharm. 2023; 21(1):137-142.
PMID: 37989273
PMC: 11228961.
DOI: 10.1021/acs.molpharmaceut.3c00667.
Molecular Insights of MAP4K4 Signaling in Inflammatory and Malignant Diseases.
Singh S, Roy R, Kumar S, Srivastava P, Jha S, Rana B
Cancers (Basel). 2023; 15(8).
PMID: 37190200
PMC: 10136566.
DOI: 10.3390/cancers15082272.
Impact of radiologic splenic vessel invasion in resectable left-sided pancreatic ductal adenocarcinoma: predictor of early systemic recurrence following upfront surgery.
Lee S, Hwang D, Lee J, Song K, Lee W, Park Y
Gland Surg. 2022; 11(10):1590-1603.
PMID: 36353584
PMC: 9638787.
DOI: 10.21037/gs-22-304.
In Pancreatic Adenocarcinoma Alpha-Synuclein Increases and Marks Peri-Neural Infiltration.
Bianchini M, Giambelluca M, Scavuzzo M, Di Franco G, Guadagni S, Palmeri M
Int J Mol Sci. 2022; 23(7).
PMID: 35409135
PMC: 8999122.
DOI: 10.3390/ijms23073775.
Technical and clinical success rates of WallFlex duodenal stents in unresectable malignant gastric outlet obstruction. A retrospective observational study from a tertiary cancer hospital in India.
Raina H, Patil P, Mehta S
Prz Gastroenterol. 2022; 17(1):41-46.
PMID: 35371362
PMC: 8942001.
DOI: 10.5114/pg.2022.114596.
Analysis of N6-methyladenosine-related lncRNAs in the tumor immune microenvironment and their prognostic role in pancreatic cancer.
Liu Y, Wang T, Fang Z, Kong J, Liu J
J Cancer Res Clin Oncol. 2022; 148(7):1613-1626.
PMID: 35314871
DOI: 10.1007/s00432-022-03985-4.
The Effects of Analgesics on the Migration of Pancreatic Cancer Cells.
Malsy M, Hackl C, Graf B, Bitzinger D, Bundscherer A
In Vivo. 2022; 36(2):576-581.
PMID: 35241509
PMC: 8931872.
DOI: 10.21873/invivo.12740.
Novel Use of Hypoxia-Inducible Polymerizable Protein to Augment Chemotherapy for Pancreatic Cancer.
Gdowski A, Hayatshahi H, Fudala R, Joshi R, Liu J, Vishwanatha J
Pharmaceutics. 2022; 14(1).
PMID: 35057024
PMC: 8777667.
DOI: 10.3390/pharmaceutics14010128.
Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma.
Liu Y, Li G, Yang Y, Lu Z, Wang T, Wang X
Front Genet. 2022; 12:752025.
PMID: 35046996
PMC: 8762218.
DOI: 10.3389/fgene.2021.752025.
Detailing the ultrastructure's increase of prion protein in pancreatic adenocarcinoma.
Bianchini M, Giambelluca M, Scavuzzo M, Di Franco G, Guadagni S, Palmeri M
World J Gastroenterol. 2021; 27(42):7324-7339.
PMID: 34876792
PMC: 8611201.
DOI: 10.3748/wjg.v27.i42.7324.
Ethanol exposure of human pancreatic normal ductal epithelial cells induces EMT phenotype and enhances pancreatic cancer development in KC (Pdx1-Cre and LSL-Kras ) mice.
Yu W, Ma Y, Roy S, Srivastava R, Shankar S, Srivastava R
J Cell Mol Med. 2021; 26(2):399-409.
PMID: 34859959
PMC: 8743655.
DOI: 10.1111/jcmm.17092.
Context Matters-Why We Need to Change From a One Size Fits all Approach to Made-to-Measure Therapies for Individual Patients With Pancreatic Cancer.
Sankarasubramanian S, Pfohl U, Regenbrecht C, Reinhard C, Wedeken L
Front Cell Dev Biol. 2021; 9:760705.
PMID: 34805167
PMC: 8599957.
DOI: 10.3389/fcell.2021.760705.
A Wavelet-Based Learning Model Enhances Molecular Prognosis in Pancreatic Adenocarcinoma.
Tang B, Chen Y, Wang Y, Nie J
Biomed Res Int. 2021; 2021:7865856.
PMID: 34697591
PMC: 8541860.
DOI: 10.1155/2021/7865856.
